EP Edge Journal Watch
By Niraj Sharma MD FACC FHRS
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Niraj Sharma MD FACC FHRS
Category: Life Sciences
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 0
Reviews: 0
Episodes: 27
Description
Welcome to EP Edge Journal Watch — where cardiac electrophysiology meets evidence, precision, and perspective.
Hosted by Dr. Niraj Sharma, this bi-weekly podcast distills high-impact cardiovascular and EP research into clear, clinically meaningful insights. Each episode goes beyond headlines and abstracts to uncover what new studies actually mean for patient care, decision-making, and the future of electrophysiology.
What EP Edge Journal Watch stands for:
Evidence-based practice
Precision electrophysiology
A forward-thinking, edge-driven approach to how we interpret and apply data in real-world clinical settings.
Whether you’re an electrophysiologist, cardiologist, researcher, trainee, or allied health professional, EP Edge Journal Watch brings you the signal — not the noise. Expect sharp summaries, thoughtful commentary, and practical takeaways designed for the busy clinician who wants to stay ahead of the curve
| Episode | Date |
|---|---|
|
EP Edge™ Journal Watch Issue 21 May 2026: AI-Guided AF Ablation, PFA/CIED Safety, VT Ablation, Cannabis and Arrhythmia Risk, HCM, HFpEF, RBBB, and Anticoagulation After AF Ablation
|
May 11, 2026 |
|
EP Edge™ Journal Watch: AVANT GUARD Trial, PFA as First-Line Therapy for Persistent AF: Half the Story
|
May 04, 2026 |
|
EP Edge™ Journal Watch Issue 20: AF Screening, Pulsed Field Ablation, ICD Shocks, CRT in AF, and Anticoagulation After Ablation
|
Apr 27, 2026 |
|
EP Edge™ Journal Watch Issue 19: Atrial Fibrillation Ablation, Conduction System Pacing, GLP-1 Therapy and Arrhythmia Risk
|
Apr 20, 2026 |
|
EP Edge™ Journal Watch Special Edition: EHRA PFA Statement 2026 | What the New Guidance Means for AF Ablation
|
Apr 14, 2026 |
|
EP Edge™ Journal Watch Issue 18 (April 2026): AF Cancer Signals, PFA Recalibration, EMBOL-AF, SMART-ALERT, LBBAP, and VT Rescue
|
Apr 13, 2026 |
|
EP Edge Journal Watch Issue 17 April 2026: CLOSURE-AF, Left Atrial Appendage Closure vs Medical Therapy, CRT Pacing Trials, PFA Cerebral Emboli, and ViV-TAVR Pacemaker Risk
|
Apr 06, 2026 |
|
EP Edge™ Journal Watch Breaking News Special Edition: CHAMPION-AF, PRAGUE-17, and CLOSURE-AF — LAAC vs DOACs in Atrial Fibrillation
|
Mar 30, 2026 |
|
EP Edge Journal Watch Issue 16: 11 New EP Trials on AF Ablation, SVT, Anticoagulation, PFA Safety, VT Pacing, and OHCA
|
Mar 23, 2026 |
|
EP Edge™ Journal Watch Issue 15: PFA Recurrence, Bayesian AF Ablation, Non-PV Triggers, Diltiazem-DOAC Risk, and Stroke Prevention After AF Ablation
|
Mar 16, 2026 |
|
EP Edge Journal Watch #14 (March 2026): AF Ablation at the Extremes: Octogenarians, HFrEF PVI-Only, LAAC, PFA Hemolysis/AKI & Redo Timing
|
Mar 09, 2026 |
|
EP Edge Journal Watch Issue 13 (March 2026): Ultrashort AF, ILR Accuracy, Semaglutide + Ablation, PADIT, PCOS, LBBAP and Next-Gen nanosecond PFA (SCENA-AF)
|
Mar 02, 2026 |
|
EP Edge™ Journal Watch: February 2026 Issue 12: AF Ablation “Success” Reframed: ADVENT-LTO 4-Year PFA Durability, 20-Year PVI Outcomes, Monitoring Rules, CIED Risks & PICM
|
Feb 23, 2026 |
|
EP Edge™ Journal Watch (Special Edition): Feb 2026 HRS/EHRA Pulsed Field Ablation (PFA) Scientific Statement — Vote Counts, Safety Signals, and Real-World Workflow
|
Feb 19, 2026 |
|
EP Edge Journal Watch Issue 11 February 2026: Varipulse Safety Signal, ElectroPulse PFA, Farapoint CTI Ablation, Leadless Pacemaker Infection & EP Occupational Hazards
|
Feb 16, 2026 |
|
EP Edge Journal Watch Issue 10, February 2026: Pulsed Field Ablation Durability, AF Ablation Outcomes, Wearable AF Detection, ICD and VT Insights
|
Feb 09, 2026 |
|
EP Edge Journal Watch Special Edition: VOLT IDE One-Year Results in Context: ADVENT, ADVANTAGE-AF, AdmIRE, SPHERE-Per-AF & U.S. PFA Pivotal Trials
|
Feb 06, 2026 |
|
EP Edge Journal Watch — Issue 9 Redefining Ventricular Tachycardia Care: From Noninvasive Radioablation to Leadless, Modular, and Drug-Based Strategies
|
Feb 02, 2026 |
|
EP Edge Journal Watch – Issue 8 (2026): VT Storm Outcomes, Inappropriate ICD Shocks, AF Ablation Modifiers, and the Rise of Patient-Directed SVT Care
|
Jan 26, 2026 |
|
EP-EDGE Journal Watch #7: Direct Oral Anti-Coagulant Adherence, AF Risk Stressors, ns-PFA Safety & EP Device Updates
|
Jan 19, 2026 |
|
LAAO vs Anticoagulation Explained: WATCHMAN FLX, AF Ablation Recurrence, Post-TAVR Heart Block & ICU AF, Hormones and TdP – EP Edge Journal Watch
|
Jan 12, 2026 |
|
Pulsed Field Ablation, Atrial Fibrillation Progression & Leadless Pacing | EP Edge Journal Watch – Jan 2026 (Issue 5)
|
Jan 05, 2026 |
|
AF Beyond the Lesion: Can We Stop Anticoagulation, Trust Sham Trials, and Treat AF as a Metabolic Disease?
|
Dec 18, 2025 |
|
EP Edge Journal Watch Issue 3: Smartwatch AFib Detection: Accuracy, False Alerts, Apple Watch ECG, and What Clinicians Need to Know
|
Nov 30, 2025 |
|
EP Edge Journal Watch: Critical Analysis: AQUATIC Trial — AF + CAD: Impact on Antithrombotic Strategy (NEJM October 2025)
|
Nov 10, 2025 |
|
EP Edge Journal Watch — November 2025, Edition 2: From Lifestyle to Lifeline
|
Nov 02, 2025 |
|
EP Edge Journal Watch | Episode 1, November 2025: Potassium and VT, GDMT Withdrawal & AF Risk Uncovered
|
Oct 30, 2025 |